ADI Global Distribution Q3 2026 Revenue Tops Estimates at $1.31B, but EPS Misses at -$8.65
Revenue of $1.31B vs. $1.27B expected and adjusted EPS of -$8.65 vs. $0.44.
ADI Global Distribution (ADIG) posted mixed third-quarter 2026 results, with revenue above the estimate and adjusted EPS below it. Revenue was $1.31 billion above the $1.27 billion estimate, and adjusted EPS was -$8.65 below the $0.44 estimate.
Shares fell 2.6% in premarket trading as of 7:05 a.m. ET, to $19.06 from a $19.57 close.
Q3 2026 scorecard
| Parameters | Expected | Actual | Beat/Miss |
|---|---|---|---|
| Adjusted EPS | $0.44 | -$8.65 | Miss by 2075% |
| Revenue | $1.27B | $1.31B | Beat by 2.7% |
| Change | QoQ |
|---|---|
| Adjusted EPS | ▼ from $0.48 |
| Revenue | ▲ 1.6% |
By our calculation, revenue was $34.1 million above the estimate and adjusted EPS was $9.09 below it. The QoQ column compares with the previous quarter's revenue of $1.29 billion and adjusted EPS of $0.48.
Track record
- EPS record. Adjusted EPS beat the estimate in 0 of the last 2 reports, including this one.
- Revenue record. Revenue beat the estimate in 2 of the last 2 reports.
- Revenue trend. Revenue over the last 3 reports, oldest first: $1.21 billion, $1.29 billion and $1.31 billion.
What to watch
- Next-quarter estimates. Consensus calls for EPS of $0.38 and revenue of $1.21 billion next quarter, based on 4 analysts.
- Estimate record. Whether ADI Global Distribution returns to beating EPS estimates, which it did in 0 of its last 2 reports.
- Share reaction. How shares trade in the next regular session after the 2.6% decline in premarket trading.
- Related coverage. See our reports on Octave Intelligence, Twist Bioscience, Generate Biomedicines and Cellebrite DI.
Sources: Results are from ADI Global Distribution's Nov. 12, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from ADI Global Distribution's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.
Readers also read
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.
